Briefing: Potential Impacts of CER on Patient Access

Briefing: Potential Impacts of CER on Patient Access

Date: November 3rd, 2010 - October 19th, 2010
Time: 3:30PM - 5:00PM
City: Washington, DC
Address: Reserve Officers Association
One Constitution Ave, NE
   

Global head-to-head trials for wet age-related macular degeneration (AMD) are currently underway and raising the issue of how their results will impact innovation and patient access.  This briefing will educate and inform stakeholders, advocates, and thought leaders on what needs to be done to ensure that CER reduces health care costs without compromising quality of care. Topics to be covered include:


·         The Aging Population and Importance Patient Access

        - Daniel Perry, Alliance for Aging Research

·         The wAMD Trials and Impact of w/AMD

      - Barbara McLaughlan, AMDAI/RNIB - Presentation

      - Andrea Densham, Prevent Blindness America - Presentation

·         Effects on Global Policy

      - Jonathan Ortmans, PFI - Presentation

·         The Role of Stakeholders

      - Chris Henshall, HTAi


Watch Video of the Event: